Study ID | Resolution of symptoms | Time to resolution of symptoms | Blood or plasma glucose concentration at 20 minutes | Resolution of hypoglycaemia | Time to resolution of hypoglycaemia | Adverse events | Treatment delay | Severe/serious adverse events (specify) |
Chlup 2009 | NI | NI | Plasma glucose tested in finger‐prick capillary blood | NI | NI | NI | NI | NI |
Barennes 2005 | NI | NI | Blood glucose concentrations, collected through finger prick | Treatment failure rate, proportion of children not reaching a blood glucose concentration of ≥ 90 mg/dL during the study period. These data were used to determine 'resolution of hypoglycaemia within 80 minutes'. Early treatment failure rate: proportion of children with no blood glucose gain at 20 minutes. These data were used to determine 'resolution of hypoglycaemia within 20 minutes' |
Time to glucose concentration normalisation | Any adverse event | NI | NI |
Slama 1990 | Clinical recovery (complete symptomatic relief) | Clinical recovery time | Plasma glucose determination, using a glucose oxidase method | NI | NI | NI | NI | NI |
Gunning 1978 | NI | NI | Number of participants with increased blood glucose at 20 minutes | NI | NI | NI | NI | NI |
aIn addition to definition of endpoint measurement, description who measured the outcome (AO: adjudicated outcome measurement; IO: investigator‐assessed outcome measurement; SO: self‐reported outcome measurement). ND: not defined; NR: not reported; NI: not investigated. |